Home Print this page Email this page Users Online: 311
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 10  |  Issue : 2  |  Page : 77-79

Intravitreal ranibizumab for postlaser anterior segment ischemia in retinopathy of prematurity

Radhatri Nethralaya, Chennai, Tamil Nadu, India

Correspondence Address:
Vasumathy Vedantham
Radhatri Nethralaya, 12, Hindi Prachar Sabha Street, T. Nagar, Chennai - 600 017, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcor.jcor_68_21

Rights and Permissions

This case report documents the successful management of anterior segment ischemia, a very rare complication following laser in retinopathy of prematurity (ROP), by intravitreal injection of Ranibizumab, an anti-vascular endothelial growth factor agent. This is the first report as per MEDLINE search on the use and efficacy of bilateral intravitreal injection of Ranibizumab in anterior segment ischemia postlaser in ROP.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded61    
    Comments [Add]    

Recommend this journal